Westfield Capital Management

Westfield Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Westfield Capital Management’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell
2020 Q2	$24.8M	Sell
2020 Q1	$29.4M	Buy
2019 Q4	$27.9M	Buy